Sangui Biotech International, Inc. – OTC:SGBI

Sangui Biotech International stock price today

$0.006
+0.00
+322.67%
Financial Health
0
1
2
3
4
5
6
7
8
9

Sangui Biotech International stock price monthly change

+33.33%
month

Sangui Biotech International stock price quarterly change

+33.33%
quarter

Sangui Biotech International stock price yearly change

-31.03%
year

Sangui Biotech International key metrics

Market Cap
 902.57K
Enterprise value
 990.89K
P/E
 -9.52
EV/Sales
 12.36
EV/EBITDA
 -23.94
Price/Sales
 12.05
Price/Book
 -0.99
PEG ratio
 -0.13
EPS
 N/A
Revenue
 91.76K
EBITDA
 -46.69K
Income
 -63.01K
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 -126.54%
Oper. margin
 -115.34%
Gross margin
 13.11%
EBIT margin
 -115.34%
EBITDA margin
 -50.88%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Sangui Biotech International stock price history

Sangui Biotech International stock forecast

Sangui Biotech International financial statements

Profit Margin

Sangui Biotech International, Inc. (OTC:SGBI): Profit margin
Jun 2022 10.50K 30.50K 290.45%
Mar 2023 18.69K -81.85K -437.78%
Jun 2023 22.68K -30.47K -134.33%
Mar 2024 39.87K 18.80K 47.16%
SGBI income statement history

Debt to Assets

Sangui Biotech International, Inc. (OTC:SGBI): Debt to assets
Dec 2022 99056 1.06M 1079.36%
Mar 2023 89104 1.09M 1233.27%
Jun 2023 90937 1.12M 1241.31%
Mar 2024 89702 1.13M 1270.2%
SGBI balance sheet history

Cash Flow

Sangui Biotech International, Inc. (OTC:SGBI): Cash Flow
Jun 2022 -37.33K 0 -1.31K
Mar 2023 251 0 -2.90K
Jun 2023 8.89K 0 8.27K
Mar 2024 2.02K 0 0
SGBI cash flow history

Sangui Biotech International other data

Sangui Biotech International
Insider Trading

Sangui Biotech International, Inc. (OTC:SGBI): Insider trades (number of shares)
Period Buy Sel
Oct 2021 0 1200000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
SCHMELZ HUBERTUS director
 Common Stock 1,200,000 $0.02 $24,000
Purchase
SCHMELZ HUBERTUS director
 Common Stock 85,000 $0.04 $2,975
Purchase
SCHMELZ HUBERTUS director
 Common Stock 20,000 $0.04 $740
Purchase
SCHMELZ HUBERTUS director
 Common Stock 91,000 $0.04 $3,185
Purchase
SCHMELZ HUBERTUS director
 Common Stock 1,190,000 $0.03 $29,750
Purchase
SCHMELZ HUBERTUS director
 Common Stock 1,190,000 $0.03 $29,750
Purchase
SCHMELZ HUBERTUS director
 Common Stock 50,000 $0.04 $2,050
Purchase
SCHMELZ HUBERTUS director
 Common Stock 1,190,000 $0.03 $29,750
Purchase
SCHMELZ HUBERTUS director
 Common Stock 60,000 $0.04 $2,520
Purchase
SCHMELZ HUBERTUS director
 Common Stock 42,000 $0.04 $1,596
SGBI insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Sangui Biotech International stock today?

    One share of Sangui Biotech International stock can currently be purchased for approximately $0.01.

  • When is Sangui Biotech International's next earnings date?

    Unfortunately, Sangui Biotech International's (SGBI) next earnings date is currently unknown.

  • Does Sangui Biotech International pay dividends?

    No, Sangui Biotech International does not pay dividends.

  • How much money does Sangui Biotech International make?

    Sangui Biotech International has a market capitalization of 902.57K and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34.47% to 93.04K US dollars.

  • What is Sangui Biotech International's stock symbol?

    Sangui Biotech International, Inc. is traded on the OTC under the ticker symbol "SGBI".

  • What is Sangui Biotech International's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of Sangui Biotech International?

    Shares of Sangui Biotech International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Sangui Biotech International's key executives?

    Sangui Biotech International's management team includes the following people:

    • Mr. Thomas Striepe Chief Executive Officer, Pres, Chief Financial Officer & Executive Director(age: 63, pay: $79,910)

  • When Sangui Biotech International went public?

    Sangui Biotech International, Inc. is publicly traded company for more then 28 years since IPO on 26 Mar 1997.

  • What is Sangui Biotech International's official website?

    The official website for Sangui Biotech International is sanguibiotech.com.

  • How can i contact Sangui Biotech International?

    Sangui Biotech International can be reached via phone at +49 40 6093120.

Sangui Biotech International company profile:

Sangui Biotech International, Inc.

sanguibiotech.com
Exchange:

OTC

Full time employees:

0

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

+49 40 6093120
BleichenbrUecke 9
Hamburg, 20354

CIK: 0001104280
ISIN: US80105B1017
CUSIP: 80105B101